Patients with aggressive subtypes of locally-advanced breast cancer may have new treatment options on the horizon, according to two reports published in July in the New England Journal of Medicine. Results of two different ...
Aug 12, 2016
0
126
(HealthDay)—An innovative set of clinical trials have identified two drugs that could provide a fighting chance for women with advanced breast cancer.
Jul 7, 2016
0
3
(HealthDay)—Neratinib and veliparib-carboplatin appear to be effective in women with specific subtypes of breast cancer, according to two studies published online July 6 in The New England Journal of Medicine.
Jul 7, 2016
0
0
The largest study ever to investigate how genetic and biological factors contribute to breast cancer risk among black women launched today. This collaborative research project will identify genetic factors that may underlie ...
Jul 6, 2016
0
1
Researchers at the University of Michigan have identified a promising new compound for targeting one of the most aggressive types of breast cancer.
Jun 8, 2016
0
719
At the American Society for Clinical Oncology (ASCO) Annual Meeting 2016, researchers present results of three clinical trials using new targeted therapies against triple negative breast cancer (TNBC). Each therapy uses a ...
Jun 3, 2016
0
3304
(HealthDay)—A new drug therapy shows promise for treating triple-negative breast cancer, an especially aggressive form of the disease, researchers say.
Jun 3, 2016
0
46
A recent study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine revealed that triple-negative breast cancer (TNBC), which has generally been unresponsive to hormone ...
May 23, 2016
0
78
In a new study using mice and lab-grown human cells, a scientific team led by Johns Hopkins Kimmel Cancer Center researchers show how a triple-drug cocktail can shrink triple-negative breast cancers by killing off cancer ...
May 19, 2016
0
2
Chemotherapy is a key part of the standard treatment regimen for triple-negative breast cancer patients whose cancer lacks expression of estrogen and progesterone receptors and the human epidermal growth factor receptor 2 ...
May 19, 2016
0
5
